These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9552758)

  • 1. An unusual case of primary systemic amyloidosis.
    Ambrosone L; Mansi L; Salvatore T; Marino F; Orabona P; Rambaldi A; Rambaldi PF; Rambaldi M
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):53-7. PubMed ID: 9552758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.
    Skinner M; Anderson J; Simms R; Falk R; Wang M; Libbey C; Jones LA; Cohen AS
    Am J Med; 1996 Mar; 100(3):290-8. PubMed ID: 8629674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized amyloidosis: a survey of 35 French cases.
    Paccalin M; Hachulla E; Cazalet C; Tricot L; Carreiro M; Rubi M; Grateau G; Roblot P
    Amyloid; 2005 Dec; 12(4):239-45. PubMed ID: 16399649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m(V)dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein.
    Kobayashi H; Sakahara H; Itoh T; Kudoh T; Takagi T; Shibuya K; Nomura S; Hosono M; Endo K; Konishi J
    J Nucl Med; 1993 May; 34(5):815-7. PubMed ID: 8386760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine.
    Schattner A; Varon D; Green L; Hurwitz N; Bentwich Z
    Am J Med; 1989 Mar; 86(3):347-8. PubMed ID: 2919619
    [No Abstract]   [Full Text] [Related]  

  • 6. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
    Kyle RA; Gertz MA; Greipp PR; Witzig TE; Lust JA; Lacy MQ; Therneau TM
    N Engl J Med; 1997 Apr; 336(17):1202-7. PubMed ID: 9110907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy options in systemic AL-amyloidosis with renal involvement].
    Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentavalent technetium-99m dimercaptosuccinic acid uptake in primary amyloidosis: comparison with autopsy findings.
    Yukihiro M; Tateno M; Hirano T; Oriuchi N; Inoue T; Iwasaki T; Murata K; Fukuda T; Nakajima T; Endo K
    Radiat Med; 1997; 15(5):317-20. PubMed ID: 9445153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m (V) DMSA uptake in amyloidosis.
    Ohta H; Endo K; Kanoh T; Konishi J; Kotoura H
    J Nucl Med; 1989 Dec; 30(12):2049-52. PubMed ID: 2555464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-(V) DMSA uptake in systemic AL amyloidosis and normal bone scintigraphy.
    Sonmez B; Cekic AB; Erkut N; Piskin B; Sonmez M
    Hell J Nucl Med; 2010; 13(1):69-70. PubMed ID: 20411178
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of primary amyloidosis with melphalan and prednisone.
    Schwartz RS; Cohen JR; Schrier SL
    Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine.
    Benson MD
    Arthritis Rheum; 1986 May; 29(5):683-7. PubMed ID: 3718560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.
    Kyle RA; Greipp PR; Garton JP; Gertz MA
    Am J Med; 1985 Dec; 79(6):708-16. PubMed ID: 3934968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of AL amyloidosis].
    Kovacsovics T
    Rev Med Suisse Romande; 2000 Oct; 120(10):771-5. PubMed ID: 11109905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Original case report of amyloidosis with pleural involvement: the role of echocardiography in the diagnosis].
    Roubille F; Billotet C; Roubille C
    Rev Med Interne; 2006 Oct; 27(10):794-6. PubMed ID: 16797793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
    Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
    Amyloid; 2009 Dec; 16(4):243-5. PubMed ID: 19922338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technetium-99m (V) dimercaptosuccinic acid myocardial scintigraphy in a 74-year-old woman with congestive heart failure].
    Hatori T; Iwasaki T; Seki R; Yamagishi T; Toyama T; Kaneko Y; Hasegawa A; Nagai R
    J Cardiol; 1998 Jun; 31(6):381-4. PubMed ID: 9666392
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follicular mucinosis with generalized para-amyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma). A demonstration of the course using melphalan-prednisone therapy with a 3 years remission].
    Jänner M; Lippert HD; Stolzenbach G
    Z Hautkr; 1977 Aug; 52(16):873-40. PubMed ID: 408988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amyloidosis in a mixed pattern. Sensitivity to colchicine and melphalan].
    Frustaci A; Gentiloni N; Feoli F
    Minerva Med; 1981 Apr; 72(15):957-60. PubMed ID: 6784038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.